» Articles » PMID: 33871799

Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2021 Apr 19
PMID 33871799
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is one of the crucial causative factors for progressive dementia. Neuropathologically, AD is characterized by the extracellular accumulation of amyloid beta plaques and intracellular neurofibrillary tangles in cortical and limbic regions of the human brain. The circadian system is one of the many affected physiological processes in AD, the dysfunction of which may reflect in the irregularity of the sleep/wake cycle. The interplay of circadian and sleep disturbances inducing AD progression is bidirectional. Sleep-associated pathological alterations are frequently evident in AD. Understanding the interrelation between circadian disruption and AD may allow for earlier identification of AD pathogenesis as well as better suited approaches and potential therapies to combat dementia. In this article, we examine the existing literature related to the molecular mechanisms of the circadian clock and interacting mechanisms of circadian disruption and AD pathogenesis.

Citing Articles

Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease.

Ragsdale S, Radovich J, Coiduras I, McCall W, Grant S, Lee C NPJ Biol Timing Sleep. 2025; 2(1):11.

PMID: 40066297 PMC: 11890173. DOI: 10.1038/s44323-025-00025-5.


Association of estimated glucose disposal rate with incident cardiovascular disease under different metabolic and circadian rhythm states: findings from a national population-based prospective cohort study.

Le C, Qin Y, Wang Z, Wang D, Zhong F, Yang S Diabetol Metab Syndr. 2024; 16(1):257.

PMID: 39472994 PMC: 11523584. DOI: 10.1186/s13098-024-01494-7.


An integrated bioinformatics analysis to identify the shared biomarkers in patients with obstructive sleep apnea syndrome and nonalcoholic fatty liver disease.

Zhang R, Liu Z, Li R, Wang X, Ai L, Li Y Front Genet. 2024; 15:1356105.

PMID: 39081807 PMC: 11286465. DOI: 10.3389/fgene.2024.1356105.


Environmental pollution and extreme weather conditions: insights into the effect on mental health.

Tota M, Karska J, Kowalski S, Piatek N, Pszczolowska M, Mazur K Front Psychiatry. 2024; 15:1389051.

PMID: 38863619 PMC: 11165707. DOI: 10.3389/fpsyt.2024.1389051.


Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease.

Han Z, Yang X, Huang S Heliyon. 2024; 10(7):e28819.

PMID: 38623196 PMC: 11016624. DOI: 10.1016/j.heliyon.2024.e28819.


References
1.
Sharma P, Sharma A, Fayaz F, Wakode S, Pottoo F . Biological Signatures of Alzheimer's Disease. Curr Top Med Chem. 2020; 20(9):770-781. DOI: 10.2174/1568026620666200228095553. View

2.
La Morgia C, Ross-Cisneros F, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G . Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2015; 79(1):90-109. PMC: 4737313. DOI: 10.1002/ana.24548. View

3.
Koronyo-Hamaoui M, Koronyo Y, Ljubimov A, Miller C, Ko M, Black K . Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2010; 54 Suppl 1:S204-17. PMC: 2991559. DOI: 10.1016/j.neuroimage.2010.06.020. View

4.
Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H . Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol. 2005; 49(2):106-8. DOI: 10.1007/s10384-004-0156-x. View

5.
Di Meco A, Joshi Y, Pratico D . Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging. 2014; 35(8):1813-20. DOI: 10.1016/j.neurobiolaging.2014.02.011. View